These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25635351)

  • 1. Actinoallolides A-E, new anti-trypanosomal macrolides, produced by an endophytic actinomycete, Actinoallomurus fulvus MK10-036.
    Inahashi Y; Iwatsuki M; Ishiyama A; Matsumoto A; Hirose T; Oshita J; Sunazuka T; Panbangred W; Takahashi Y; Kaiser M; Otoguro K; Ōmura S
    Org Lett; 2015 Feb; 17(4):864-7. PubMed ID: 25635351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and heterologous expression of the actinoallolide biosynthetic gene cluster.
    Inahashi Y; Shiraishi T; Také A; Matsumoto A; Takahashi Y; Ōmura S; Kuzuyama T; Nakashima T
    J Antibiot (Tokyo); 2018 Aug; 71(8):749-752. PubMed ID: 29679043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of the actinoallolides and a designed photoaffinity probe for target identification.
    Anketell MJ; Sharrock TM; Paterson I
    Org Biomol Chem; 2020 Oct; 18(40):8109-8118. PubMed ID: 33015697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Unified Total Synthesis of the Actinoallolides, a Family of Potent Anti-Trypanosomal Macrolides.
    Anketell MJ; Sharrock TM; Paterson I
    Angew Chem Int Ed Engl; 2020 Jan; 59(4):1572-1576. PubMed ID: 31743574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-trypanosomal activity of doubly modified salinomycin derivatives.
    Antoszczak M; Steverding D; Sulik M; Janczak J; Huczyński A
    Eur J Med Chem; 2019 Jul; 173():90-98. PubMed ID: 30986574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-trypanosomal activities of DNA topoisomerase inhibitors.
    Deterding A; Dungey FA; Thompson KA; Steverding D
    Acta Trop; 2005 Mar; 93(3):311-6. PubMed ID: 15715983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antitrypanosomal activity of 12 low-molecular-weight antibiotics and observations of structure/activity relationships.
    Iwatsuki M; Otoguro K; Ishiyama A; Namatame M; Nishihara-Tukashima A; Hashida J; Nakashima T; Masuma R; Takahashi Y; Yamada H; Omura S
    J Antibiot (Tokyo); 2010 Oct; 63(10):619-22. PubMed ID: 20717119
    [No Abstract]   [Full Text] [Related]  

  • 8. Compounds containing 2-substituted imidazole ring for treatment against human African trypanosomiasis.
    Samant BS; Sukhthankar MG
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1015-8. PubMed ID: 21211967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives.
    Salado IG; Baán A; Verdeyen T; Matheeussen A; Caljon G; Van der Veken P; Kiekens F; Maes L; Augustyns K
    Eur J Med Chem; 2018 May; 151():18-26. PubMed ID: 29604541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems.
    Hannaert V
    Planta Med; 2011 Apr; 77(6):586-97. PubMed ID: 20945274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising lead compounds for novel antiprotozoals.
    Otoguro K; Iwatsuki M; Ishiyama A; Namatame M; Nishihara-Tukashima A; Shibahara S; Kondo S; Yamada H; Omura S
    J Antibiot (Tokyo); 2010 Jul; 63(7):381-4. PubMed ID: 20661239
    [No Abstract]   [Full Text] [Related]  

  • 13. Kola acuminata proanthocyanidins: a class of anti-trypanosomal compounds effective against Trypanosoma brucei.
    Kubata BK; Nagamune K; Murakami N; Merkel P; Kabututu Z; Martin SK; Kalulu TM; Huq M; Yoshida M; Ohnishi-Kameyama M; Kinoshita T; Duszenko M; Urade Y
    Int J Parasitol; 2005 Jan; 35(1):91-103. PubMed ID: 15619520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.
    Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ
    Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of selective tubulin inhibitors as anti-trypanosomal agents.
    Bobba V; Nanavaty V; Idippily ND; Zhao A; Li B; Su B
    Bioorg Med Chem; 2017 Jun; 25(12):3215-3222. PubMed ID: 28428042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro trypanocidal activity of the anti-helminthic drug niclosamide.
    Merschjohann K; Steverding D
    Exp Parasitol; 2008 Apr; 118(4):637-40. PubMed ID: 18226810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
    Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
    Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arenicolides A-C, 26-membered ring macrolides from the marine actinomycete Salinispora arenicola.
    Williams PG; Miller ED; Asolkar RN; Jensen PR; Fenical W
    J Org Chem; 2007 Jul; 72(14):5025-34. PubMed ID: 17266372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents.
    Demoro B; Sarniguet C; Sánchez-Delgado R; Rossi M; Liebowitz D; Caruso F; Olea-Azar C; Moreno V; Medeiros A; Comini MA; Otero L; Gambino D
    Dalton Trans; 2012 Feb; 41(5):1534-43. PubMed ID: 22138896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.